BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jul 16, 2012
 |  BioCentury  |  Politics, Policy & Law

Commentary: PDUFA fish wrap

White House puts PDUFA V signing on par with upgrade of Washington fish market

Are FDA, the companies and products it regulates and the patients who rely on them more important than Washington's fish market? Not to the White House.

As the father of progressive politics Teddy Roosevelt noted, the presidency is a "bully pulpit." Among the most important things presidents do is set and announce priorities; there is not a day when the White House does not try to shape the national discussion.

Last Monday, President Obama and the staff that runs his messaging machine had an opportunity to turn the nation's attention, at least briefly, to biomedical innovation. The White House could have gathered FDA officials, patient advocates, biopharma companies, Republicans and Democrats, to witness the president signing the FDA Safety and Innovation Act (FDASIA) that reauthorizes PDUFA.

This would have demonstrated that FDA is a source of pride for the...

Read the full 673 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >